These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 12868560)
1. In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates. Kantarcioglu AS; Yucel A; Vidotto V J Chemother; 2003 Jun; 15(3):296-8. PubMed ID: 12868560 [No Abstract] [Full Text] [Related]
2. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726 [TBL] [Abstract][Full Text] [Related]
3. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). Messer SA; Moet GJ; Kirby JT; Jones RN J Clin Microbiol; 2009 Jun; 47(6):1942-6. PubMed ID: 19386851 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods. Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915 [TBL] [Abstract][Full Text] [Related]
5. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program. Pfaller MA; Messer SA; Rhomberg PR; Castanheira M Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853 [TBL] [Abstract][Full Text] [Related]
6. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis. Kakeya H; Miyazaki Y; Senda H; Kobayashi T; Seki M; Izumikawa K; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S Antimicrob Agents Chemother; 2008 May; 52(5):1871-2. PubMed ID: 18299408 [TBL] [Abstract][Full Text] [Related]
8. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies. Du W; Gao Y; Liu L; Sai S; Ding C Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268 [TBL] [Abstract][Full Text] [Related]
9. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320 [TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012). Pfaller MA; Messer SA; Jones RN; Castanheira M J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine. Strippoli V; Torosantucci A; Simonetti N Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. Mitsuyama J; Nomura N; Hashimoto K; Yamada E; Nishikawa H; Kaeriyama M; Kimura A; Todo Y; Narita H Antimicrob Agents Chemother; 2008 Apr; 52(4):1318-24. PubMed ID: 18227186 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343 [TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan. Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422 [TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of C-27 steroidal saponins. Yang CR; Zhang Y; Jacob MR; Khan SI; Zhang YJ; Li XC Antimicrob Agents Chemother; 2006 May; 50(5):1710-4. PubMed ID: 16641439 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antifungal evaluation of 7-arylamino-5,8-dioxo-5,8-dihydroisoquinoline-4-carboxylates. Ryu CK; Song AL; Hong JA Bioorg Med Chem Lett; 2013 Apr; 23(7):2065-8. PubMed ID: 23453842 [TBL] [Abstract][Full Text] [Related]
19. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236 [TBL] [Abstract][Full Text] [Related]